Eribulin Does Not Prevent Epithelial-to-Mesenchymal Transition in HT-29 Intestinal Epithelial Cells

BACKGROUND: Fistula formation affects up to 50$ of Crohn's disease (CD) patients and causes considerable morbidity. Current pharmacological management mainly includes antibiotics, immunosuppressives, and anti-TNF antibodies. CD fistulas develop from intestinal epithelial cells undergoing epithe...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Inflamm Intest Dis
Autors principals: Leutenegger, Martin, Bruckner, Ramona, Spalinger, Marianne R., Lang, Silvia, Rogler, Gerhard, Scharl, Michael
Format: Artigo
Idioma:Inglês
Publicat: S. Karger AG 2018
Matèries:
Original Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6135225/
https://ncbi.nlm.nih.gov/pubmed/30221148
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000490052
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars